Trials / Unknown
UnknownNCT05298761
Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery
Efficacy of IV Lignocaine Versus IV Nalbuphine for Attenuation of Pressor Response Diring Laryngoscopy and Intubation in Patients Planned for Thyroid Surgery
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Sheikh Zayed Medical College · Other Government
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lignocaine | Inj lignocain and inj nalbuphine given to two groups of participants and effects of both drugs |
Timeline
- Start date
- 2023-12-30
- Primary completion
- 2024-03-01
- Completion
- 2024-06-01
- First posted
- 2022-03-28
- Last updated
- 2023-11-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05298761. Inclusion in this directory is not an endorsement.